Integrated Filing — IndAS



General information about company

Scrip Code 543252
NSE Symbol FAIRCHEMOR
MSEI Symbol NOTLISTED
ISIN INE0DNW01011
Name of company Fairchem Organics Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 06-02-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 23-01-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Third quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Speciality Chemicals
Start date and time of board meeting 06-02-2026   15:20:00
End date and time of board meeting 06-02-2026   16:00:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 10,013.40 34,271.98
Other income 25.74 76.53
Total income 10,039.14 34,348.51
2 Expenses
(a) Cost of materials consumed 7,486.74 26,431.03
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 588.48 1,214.12
(d) Employee benefit expense 600.06 1,738.52
(e) Finance costs 96.17 257.65
(f) Depreciation, depletion and amortisation expense 279.59 830.63
(f) Other Expenses
1 Power and Fuel 386.98 1,710.01
2 Other Expenses 533.36 1,819.47
Total other expenses 920.34 3,529.48
Total expenses 9,971.38 34,001.43
3 Total profit before exceptional items and tax 67.76 347.08
4 Exceptional items (88.27) (88.27)
5 Total profit before tax (20.51) 258.81
6 Tax expense
7 Current tax (25.45) (4.35)
8 Deferred tax 14.65 78.29
9 Total tax expenses (10.80) 73.94
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations (9.71) 184.87
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period (9.71) 184.87
17 Other comprehensive income net of taxes 40.59 23.87
18 Total Comprehensive Income for the period 30.88 208.74
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,302.09 1,302.09
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -0.07 1.42
Diluted earnings (loss) per share from continuing operations -0.07 1.42
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -0.07 1.42
Diluted earnings (loss) per share from continuing and discontinued operations -0.07 1.42
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes: 1. The above unaudited financial results, as reviewed by Audit Committee, are subsequently approved by the Board of Directors at their meetings held on February 06, 2026. The Statutory Auditors have performed limited review of the Company's financial results for the quarter and nine months ended on December 31, 2025. The Statutory Auditors have expressed an unmodified review conclusion. 2. The unaudited financial results of the Company have been prepared in accordance with Indian Accounting Standards (‘Ind AS’) prescribed under Section 133 of the Companies Act, 2013 read with the relevant rules issued thereunder and in terms of the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 3. The Company is engaged in the business of manufacturing of speciality chemicals viz. Oleo Chemicals and Intermediate Nutraceuticals. Considering the nature of Company’s business, as well as based on review of operating results by the chief operating decision maker to make decisions about resource allocation and performance measurement, there is only one reportable business segment in accordance with the requirements of IND AS 108 – “Operating Segments”. Sr. No. Particulars (Rs. In Lakhs) Quarter ended Nine Months ended Year ended 31-Dec-2025 30-Sep-2025 31-Dec-2024 31-Dec-2025 31-Dec-2024 31-Mar-2025 Unaudited Unaudited Unaudited Unaudited Unaudited Audited I Segment Revenue Speciality Chemicals 10,013.40 11,152.27 11,357.08 34,271.98 41,711.77 53,789.84 II Segment Results Speciality Chemicals 161.51 178.36 563.80 601.56 3,151.18 3,352.99 Less: Finance cost (96.17) (60.96) (92.63) (257.65) (275.63) (366.63) Add: Interest Income 2.42 0.36 0.43 3.17 5.26 5.68 Profit Before Tax and Exceptional Items 67.76 117.76 471.60 347.08 2,880.81 2,992.04 Less: Exceptional Items (Note 5) (88.27) - - (88.27) - - Profit Before Tax (20.51) 117.76 471.60 258.81 2,880.81 2,992.04 III Segment Assets Speciality Chemicals 38,056.27 38,838.51 36,344.18 38,056.27 36,344.18 40,182.88 IV Segment Liabilities Speciality Chemicals 8,621.01 9,434.16 6,193.16 8,621.01 6,193.16 9,979.82 4. The Company does not have any subsidiary/associate/joint venture company as on December 31,2025. 5. The Government of India has implemented four new Labour Codes, including the Codes on Wages,2019 w.e.f. November 21, 2025. The Ministry of Labour & Employment published draft Central Rules and FAQs to enable assessment of the financial impact due to changes in regulations. Based on management’s assessment, actuarial valuation and in line with ICAI guidance, the Company has recognised additional employee benefit obligation of Rs.88.27 Lakhs which has been disclosed as an Exceptional item in the financial results for the quarter and nine months ended December 31, 2025. The Company continues to monitor the finalization of Central/ State Rules and clarifications from the Government on other aspects of the Labour Codes and would provide appropriate accounting effect as and when such clarifications are issued/rules are notified. 6. The Members of the Company through Postal Ballot approved the Special Resolution dated December 26, 2025, for Buyback of upto 4,25,000 fully paid-up Equity Shares of face value of Rs. 10/- each, representing 3.26% of the total number of the Equity Shares in the paid-up Share Capital of the Company as on March 31, 2025, through a Tender Offer route, at a price of Rs. 800/- per Equity Share, payable in cash, for an aggregate amount not exceeding Rs. 34 Crores. The Buyback offer was commenced on January 8, 2026, and closed on January 14, 2026. The settlement of all valid bids was completed on January 21, 2026, and 4,25,000 Equity Shares, which were tendered and accepted in Buyback were extinguished on January 27, 2026. 7. Investors can view the unaudited financial results of the Company for the quarter and nine months ended on December 31, 2025 on the Company's website www.fairchem.in, on the website of the BSE www.bseindia.com and on the website of NSE www.nseindia.com. For and on behalf of the Board of Directors, For Fairchem Organics Limited, Place: Chekhala, Taluka Sanand, Nahoosh Jariwala Dist. AHMEDABAD Chairman and Managing Director Date: February 06, 2026 (DIN: 00012412)



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-10-2025 01-04-2025
Date of end of reporting period 31-12-2025 31-12-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement (Losses)/Gains on Post Employment Defined Benefit Plans 54.25 31.90
Total Amount of items that will not be reclassified to profit and loss 54.25 31.90
2 Income tax relating to items that will not be reclassified to profit or loss 13.66 8.03
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income 40.59 23.87





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 B S R and Co. Yes 30-04-2026